Effect of Eluxadoline on Health-Related Quality of Life in Adults With Irritable Bowel Syndrome With Diarrhea: Results From Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials

被引：0
|
作者：
Andrae, David
Buono, Jessica L.
Covington, Paul S.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1385
引用
收藏
页码：S494 / S494
页数：1
相关论文
共 50 条
  • [31] Randomized double-blind placebo-controlled study to evaluate the effect of long-acting mesalamine on postinfectious irritable bowel syndrome with diarrhea
    Tuteja, Ashok K.
    Leung, Daniel T.
    Fang, John C.
    Talley, Nicholas. J.
    Stoddard, Gregory J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36 (10):
  • [32] The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea
    Abel, Jessica L.
    Carson, Robyn T.
    Andrae, David A.
    QUALITY OF LIFE RESEARCH, 2019, 28 (02) : 369 - 377
  • [33] A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome
    Masand, Prakash S.
    Pae, Chi-Un
    Krulewicz, Stan
    Peindl, Kathleen
    Mannelli, Paolo
    Varia, Indu M.
    Patkar, Ashwin A.
    PSYCHOSOMATICS, 2009, 50 (01) : 78 - 86
  • [34] A randomized, placebo-controlled, double-blind trial of paroxetine controlled release (CR) in irritable bowel syndrome
    Masand, P. S.
    Peindl, K.
    Krulewicz, S.
    Varia, I.
    Patkar, A. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S137 - S137
  • [35] A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
    Mack, Isabelle
    Schwille-Kiuntke, Juliane
    Mazurak, Nazar
    Niesler, Beate
    Zimmermann, Kurt
    Moennikes, Hubert
    Enck, Paul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : 1039 - +
  • [36] Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
    Cash, Brooks D.
    Pimentel, Mark
    Rao, Satish S. C.
    Weinstock, Leonard
    Chang, Lin
    Heimanson, Zeev
    Lembo, Anthony
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (09) : 689 - 699
  • [37] Efficacy of Chinese Herbal Medicine for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
    Zhu, Jia-Jie
    Liu, Shan
    Su, Xiao-Lan
    Wang, Zi-Song
    Guo, Yu
    Li, Yi-Jie
    Yang, Yang
    Hou, Li-Wei
    Wang, Qing-Guo
    Wei, Ru-Han
    Yang, Jian-Qin
    Wei, Wei
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [38] Factor Analyses of Patient-Reported Outcome Measures in Irritable Bowel Syndrome With Constipation: Results From 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Trials of Linaclotide
    Williams, Valerie
    Nelson, Lauren
    Carson, Robyn
    Baird, Mollie
    Coon, Cheryl
    Fehnel, Sheri
    Johnston, Jeffrey
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S587 - S587
  • [39] Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial
    Lacy, Brian E.
    King, Jennifer
    Shortino, Denise
    Schaumburg, Chris
    Haag-Molkenteller, Cornelia
    Chey, William D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 34 (12):
  • [40] The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
    Sun, Yi-Yuan
    Li, Ming
    Li, Yue-Yue
    Li, Li-Xiang
    Zhai, Wen-Zhe
    Wang, Peng
    Yang, Xiao-Xiao
    Gu, Xiang
    Song, Li-Jin
    Li, Zhen
    Zuo, Xiu-Li
    Li, Yan-Qing
    SCIENTIFIC REPORTS, 2018, 8
12345